U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Epidermal iontophoresis device

Patent 4141359 Issued on February 27, 1979. Estimated Expiration Date: Icon_subject August 16, 1996. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3289671

3683923

3918459

Test and control device for electrosurgical apparatus
Patent #: 3933157
Issued on: 01/20/1976
Inventor: Bjurwill ,   et al.

Iontophoresis apparatus for applying local anesthetics Patent #: 3991755
Issued on: 11/16/1976
Inventor: Vernon ,   et al.

Inventors

Application

No. 05/714942 filed on 08/16/1976

US Classes:

604/20, Infrared, visible light, ultraviolet, X-ray or electrical energy applied to body (e.g., iontophoresis, etc.)607/63, Promoting patient safety or comfort607/64, Constant level output607/72Pulse signal

Examiners

Primary: Cohen, Lee S.

Attorney, Agent or Firm

International Classes

A61N 1/30 (20060101)
A61N 1/32 (20060101)

Abstract

An improved iontophoresis device for topical administration of ionic drugs or chemicals through epidermal tissue for anesthetizing or sterilizing local tissue or for applying various medicaments without mechanical penetration. An ionic form of drug is conducted through the epidermal tissue by means of direct current generated from a battery powered current source. Pulse-width modulated DC current is regulated by feedback circuitry which varies the pulse duration and adjusts and stabilizes the average current at a desired level. A high voltage capability together with feedback control enables maintenance of a constant current through the highly resistive epidermal tissue. To prevent excessive voltage buildup and the accompanying dangers of shock and burns, a comparator circuit monitors current flow and voltage across the electrodes and automatically triggers an SCR shutdown circuit when impedance readings are outside predetermined limits. The ionic drug is suspended in a conductive gel mixture which acts as the conducting medium in direct communication with the patient's skin. This gel is carried in a receptacle mounted on an electrode pad which uses a conducting foil surface to make electrical contact with the gel.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?